Christopher Bunick, MD, PhD, and James Del Rosso, DO: Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% to Treat Acne Induced by Janus Kinase Inhibitor Treatment: A Case Report

September 11, 2025

Drs. Bunick and Del Rosso discuss an article published in JCAD September 2025, titled “Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% to Treat Acne Induced by Janus Kinase Inhibitor Treatment: A Case Report.”

Read the full article here

Reference:

Olszewski N and Bunick CG. Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% to Treat Acne Induced by Janus Kinase Inhibitor Treatment: A Case Report. J Clin Aesthet Dermatol. 2025;18(9):36–39.

MORE JOURNAL REVIEWS

Marianna Blyumin-Karasik, MD: What Are Topical Adaptogens? A Systematic Review and Proposed System to Identify and Categorize Skin Adaptogens in Dermatology

Dr. Blyumin-Karasik discusses her article published in JCAD September 2025, titled “What Are Topical Adaptogens? A Systematic Review and Proposed System to Identify and Categorize...

PLAY

Christopher Bunick, MD, PhD, and James Del Rosso, DO: Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% to Treat Acne Induced by Janus Kinase Inhibitor Treatment: A Case Report

Drs. Bunick and Del Rosso discuss an article published in JCAD September 2025, titled “Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% to Treat Acne Induced by...

PLAY

Diego Ruiz Dasilva, MD: Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case Series

Dr. Dasilva discusses his article published in JCAD September 2025, titled “Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case Series.” Read...

PLAY

Emmy Graber, MD, MBA: Prospective Pilot Evaluation of the Safety, Tolerability, and Efficacy of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel plus Clascoterone 1% Cream in Adult Patients with Acne

Dr. Emmy Graber presents pilot study results on a combination acne regimen featuring clindamycin/adapalene/BPO gel plus clascoterone cream in adult patients. Topics Covered: Combination topical...

PLAY

Naiem T. Issa, MD, PhD: Real-World Use of Tapinarof Cream 1% Once Daily in Patients with Seborrheic Dermatitis: A Case Series

Dr. Naiem T. Issa presents a case series on the real-world application of Tapinarof Cream 1% once daily in patients with seborrheic dermatitis, highlighting its...

PLAY

Nada Elbuluk, MD, MSc: Utilization of Internet and Social Media by Outpatient Dermatology Patients: A Prospective, Cross-sectional Study

Dr. Nada Elbuluk presents findings on how outpatient dermatology patients use the internet and social media to acquire dermatology-related information. Topics Covered: Patient behavior in...

PLAY

Tina Bhutani, MD: Improvement in Patient-reported Symptoms and Satisfaction with Tildrakizumab in a Real-world Study in Patients with Moderate-to-severe Plaque Psoriasis

Dr. Tina Bhutani reviews real-world data showing improved patient-reported outcomes and satisfaction with tildrakizumab in moderate-to-severe plaque psoriasis. Topics Covered: Tildrakizumab 100mg over 64 weeks...

PLAY

Alice Gottlieb, MD, PhD: Diagnostic Delay of Psoriatic Arthritis of More Than Six Months Contributes to Poor Patient-Reported Outcome Measures in Depression, Social Ability, and Disease Impact

Alice Gottlieb, MD, PhD, discusses a new article published in the October 2024 issue of JCAD that sought to correlate the time lag between psoriatic...

PLAY

James Del Rosso, DO: Clindamycin— A Comprehensive Status Report with Emphasis on Use in Dermatology

James Del Rosso, DO, Clinical Editor-in-Chief of JCAD, discusses a new review article published in the August 2024 issue of JCAD, titled “Clindamycin: A Comprehensive...

PLAY

Marianna Blyumin-Karasik, MD: What Are Topical Adaptogens? A Systematic Review and Proposed System to Identify and Categorize Skin Adaptogens in Dermatology

Dr. Blyumin-Karasik discusses her article published in JCAD September 2025, titled “What Are Topical Adaptogens? A Systematic Review and Proposed System to Identify and Categorize

Diego Ruiz Dasilva, MD: Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case Series

Dr. Dasilva discusses his article published in JCAD September 2025, titled “Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case Series.” Read

Emmy Graber, MD, MBA: Prospective Pilot Evaluation of the Safety, Tolerability, and Efficacy of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel plus Clascoterone 1% Cream in Adult Patients with Acne

Dr. Emmy Graber presents pilot study results on a combination acne regimen featuring clindamycin/adapalene/BPO gel plus clascoterone cream in adult patients. Topics Covered: Combination topical

Naiem T. Issa, MD, PhD: Real-World Use of Tapinarof Cream 1% Once Daily in Patients with Seborrheic Dermatitis: A Case Series

Dr. Naiem T. Issa presents a case series on the real-world application of Tapinarof Cream 1% once daily in patients with seborrheic dermatitis, highlighting its

Nada Elbuluk, MD, MSc: Utilization of Internet and Social Media by Outpatient Dermatology Patients: A Prospective, Cross-sectional Study

Dr. Nada Elbuluk presents findings on how outpatient dermatology patients use the internet and social media to acquire dermatology-related information. Topics Covered: Patient behavior in

Tina Bhutani, MD: Improvement in Patient-reported Symptoms and Satisfaction with Tildrakizumab in a Real-world Study in Patients with Moderate-to-severe Plaque Psoriasis

Alice Gottlieb, MD, PhD: Diagnostic Delay of Psoriatic Arthritis of More Than Six Months Contributes to Poor Patient-Reported Outcome Measures in Depression, Social Ability, and Disease Impact

Alice Gottlieb, MD, PhD, discusses a new article published in the October 2024 issue of JCAD that sought to correlate the time lag between psoriatic

JCAD Archives

Christopher Bunick, MD, PhD, and James Del Rosso, DO: Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% to Treat Acne Induced by Janus Kinase Inhibitor Treatment: A Case Report

MORE JOURNAL REVIEWS

Marianna Blyumin-Karasik, MD: What Are Topical Adaptogens? A Systematic Review and Proposed System to Identify and Categorize Skin Adaptogens in Dermatology

Diego Ruiz Dasilva, MD: Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case Series

Emmy Graber, MD, MBA: Prospective Pilot Evaluation of the Safety, Tolerability, and Efficacy of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel plus Clascoterone 1% Cream in Adult Patients with Acne

Naiem T. Issa, MD, PhD: Real-World Use of Tapinarof Cream 1% Once Daily in Patients with Seborrheic Dermatitis: A Case Series

Nada Elbuluk, MD, MSc: Utilization of Internet and Social Media by Outpatient Dermatology Patients: A Prospective, Cross-sectional Study

Tina Bhutani, MD: Improvement in Patient-reported Symptoms and Satisfaction with Tildrakizumab in a Real-world Study in Patients with Moderate-to-severe Plaque Psoriasis

Alice Gottlieb, MD, PhD: Diagnostic Delay of Psoriatic Arthritis of More Than Six Months Contributes to Poor Patient-Reported Outcome Measures in Depression, Social Ability, and Disease Impact

James Del Rosso, DO: Clindamycin— A Comprehensive Status Report with Emphasis on Use in Dermatology

Journal Review: Andrew Blauvelt

Journal Review: Linda Stein Gold

Journal Review: Valerie Callender

Journal Review: Nanette Silverberg (Full Manuscript)

Journal Review: Sabrina Fabi